BioLineRx Presents Positive Safety and Efficacy Results for Novel Stem-Cell … – MarketWatch
|
BioLineRx Presents Positive Safety and Efficacy Results for Novel Stem–Cell …
MarketWatch Treatment with BL-8040 as a single agent was found safe and well tolerated at all doses, and resulted in efficient stem–cell mobilization and collection in all study participants. Furthermore, the results support BL-8040 as a one-day, single-dose … |
